Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Retirement Plan Administrator

Pattison Pension
(Albuquerque NM / Hybrid)

Pattison Pension logo

Defined Benefit Plan Consultant/Actuarial Analyst

Sentinel Group
(Remote / Everett MA)

Sentinel Group logo

Strategic Retirement Plan Consultant

Retirement Plan Consultants
(Urbandale IA / Des Moines IA)

Retirement Plan Consultants logo

Retirement Plan Consultant

MAP Retirement
(Remote)

MAP Retirement logo

Plan Administrator, Defined Benefit & Cash Balance

The Pension Source
(Remote / Stuart FL / NY / TX / Hybrid)

The Pension Source logo

Regional Vice President, Sales

MAP Retirement
(Remote)

MAP Retirement logo

Temporary Document Specialist

BPAS
(Utica NY)

BPAS logo

Data Administrator II

DWC - The 401(k) Experts
(Remote)

DWC - The 401(k) Experts logo

Plan Consultant - DB/CB

MAP Retirement
(Remote)

MAP Retirement logo

Retirement Plan Consultant

Sentinel Group
(Remote / Everett MA)

Sentinel Group logo

Retirement Relationship Manager

MAP Retirement
(Remote)

MAP Retirement logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile app icon
LinkedIn icon     Twitter icon     Facebook icon
Webinars
and Podcasts
  >  Upcoming   |   On-Demand
Conferences   >  Upcoming   |   Grouped by Location
All Webinars, Podcasts and Conferences   >  Upcoming   |   Grouped by Sponsor

View More Ropes & Gray Webinars, Podcasts and Conferences

Can Agencies Do That? Limits to Executive Action Regarding Drug Pricing

Ropes & Gray

Dec. 1, 2022
On-Demand
Podcast

In this Ropes & Gray podcast, health care partners Margaux Hall and Stephanie Webster and counsel David Ault explore drug pricing reforms and limits on agency action. In the months leading up to the midterm elections, we saw a flurry of activity around drug pricing, and now, in the wake of midterms, we see heightened bipartisan interest in the topic. Listen in to hear about some of the key recent events and a discussion on the fundamental question of how far agencies can go in regulating drug pricing.

More Information, How to Register